Biomarin Pharmaceutical - Registered Shares Profit Margin

As of the most recent data (June 2026), BMRN shows a profit margin of 2.14%. That compares with 14.48% in the prior-year period — down 85.2% year over year. That is below the Healthcare sector average of 21.34%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BMRN's profit margin is now 2.14% (was 14.48%) — a 85.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Biomarin Pharmaceutical - Registered Shares is outperforming or lagging.

The Healthcare sector average profit margin is about 21.34%. Biomarin Pharmaceutical - Registered Shares is at 2.14%, which is lower that average. That is roughly 90.0% below the sector mean. Use the comparison chart on this page to see how BMRN stacks up against individual peers as well.

That compares with 14.48% in the prior-year period — down 85.2% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Biomarin Pharmaceutical - Registered Shares with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Biomarin Pharmaceutical - Registered Shares's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 2.14%) with ownership activity and broader fundamentals.